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Abstract 
The ubiquitin-26S proteasome degradation system (UPS) plays a pivotal role in almost all 
aspects of plant life, including defending against pathogens. While the proteasome is 
important for plant immunity, it has been found to also be exploited by pathogens using 
effectors to increase their virulence. Recent work on the XopJ effector and syringolin 
A/syrbactins has highlighted host proteasome inhibition as a virulence strategy of pathogens. 
This review will focus on these recent developments.  
 
The ubiquitin-26S proteasome degradation system (UPS) and plant immunity 
Besides the lysosome, the UPS is the main protein degradation system of eukaryotic cells that 
not only destructs misfolded proteins but is also involved in many cellular processes by 
degrading proteins regulating such processes [1, 2]. Proteins destined for destruction by the 
proteasome become polyubiquitinated by a reaction cascade involving three enzymes 
designated E1, E2, and E3. Ubiquitin is activated in an ATP-dependent way by E1 and 
transferred to E2, from which it is normally directly transferred to a lysine residue of the 
target protein by E3, which, by selecting target proteins, confers specificity to the UPS [3]. 
Polyubiquitination is achieved by multiple rounds in which further ubiquitin units are 
conjugated to an internal lysine residue of ubiquitin. Polyubiquitinated proteins are substrates 
for the proteasome, which is composed of two 19S regulatory particles (RP) capping a 20S 
core particle (CP). The RPs recognize polyubiquitinated proteins, which become 
deubiquitinated and unfolded in an ATP-dependent reaction, and regulate access of unfolded 
substrates to the proteolytic channel of the CP. The channel is formed by four stacked seven-
membered rings. The two identical outer rings consist of seven different α-subunits, whereas 
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the two identical inner rings consist of seven different β-subunits, three of which have 
proteolytic activities: the β1 subunit exhibits a caspase-like activity (CL), cleaving protein 
substrates after acidic residues, while the β2 and β5 subunits have trypsin-like (TL) and 
chymotrypsin-like (ChTL) activities cleaving after basic and hydrophobic residues, 
respectively. In all three catalytic subunits, the active site residue is the N-terminal threonine 
(Thr) [4].  
 The UPS is involved in the signaling pathways of nearly all plant hormones, including 
salicylic acid (SA), jasmonic acid (JA), and ethylene (ET), hormones of particular importance 
for plant defense against pathogens [5]. SA plays a prominent role in defense reactions 
directed mainly against biotrophic pathogens [6]. Many of the SA-dependent defense 
reactions, such as PR (PATHOGENESIS-RELATED) gene activation, require the key 
regulator NPR1 (NONEXPRESSOR OF PR GENES 1), which must be turned over by the 
UPS to function properly [7]. In contrast, JA and ET orchestrate defense reactions mainly 
directed against necrotrophic pathogens [6]. The JA receptor is part of an E3 ligase targeting 
JAZ (JA ZIM domain) proteins for proteasomal destruction. The destruction of JAZ proteins  
releases transcription factors such as MYC2 from sequestration by JAZ proteins and thus 
leads to the activation of JA response genes [8]. The UPS is also required at multiple steps in 
ET signaling, such as the regulation of ET biosynthesis and downstream signaling 
components.  In addition to these three well-known defense hormones, other hormones such 
as auxin, gibberellic acid, and abscisic acid, which all require the UPS in their signal 
transduction pathways, have also been shown to affect the interactions of plants with 
pathogens [9]. Apart from hormone signaling, a considerable number of E3 ligases and other 
UPS components have been found to play a role in plant immunity, further testifying to the 
importance of the UPS in pathogen defense [10]. 
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Exploitation of the UPS by pathogens 
Not only is the UPS involved in many aspects of plant immunity, but a variety of plant and 
animal pathogens subvert the host UPS for their own good [11]. To see how, it may be helpful 
to shortly summarize the major paradigms of plant defense against pathogens. As worked out 
mainly in the model plant Arabidopsis thaliana, plants have evolved a two-branched innate 
immune system to combat pathogens [12]. One branch is named pattern-triggered immunity 
(PTI) and involves a plethora of physiological and cellular defense responses adverse to 
pathogens, conferring basal resistance. PTI is launched after recognition of pathogens (or 
microbe)-associated molecular patterns (PAMPs or MAMPs) by membrane-bound pattern 
recognition receptors (PRRs), which exhibit structural similarity to the Toll-like innate 
immune receptors in mammals and insects [13, 14]. Bacterial pathogens are able to suppress 
PTI by using their type III secretion system (T3SS) to inject effector proteins (T3Es) into the 
cytoplasm of host plant cells where they block PTI-associated signaling at many points, thus 
resulting in effector-triggered susceptibility (ETS) [15, 16]. However, plants have evolved a 
second branch of innate immunity dubbed effector-triggered immunity (ETI), in which 
specific effectors are recognized by cognate resistance (R) proteins. This usually results in a 
hypersensitive reaction (HR), a form of local programmed cell death conferring nearly 
complete but race-specific resistance [17]. In many plants, local HR induces systemic 
acquired resistance against a broad spectrum of pathogens in remote tissues [18]. T3Es are 
known to interfere with all these defense reactions at various points [15, 16]. 
 Analyses of several plant–pathogen interaction systems have identified a number of 
T3Es that require the host proteasome for their defense-suppressing activities, thus subverting 
it for their own use [11]. A well-studied example is HopAB2 (alias AvrPtoB) produced by the 
tomato pathogen Pseudomonas syringae pv. tomato (Pst) DC3000 and some other strains that 
exhibits E3 ligase activity and targets host defense proteins such as PRRs for proteasomal 
destruction [19-23]. Recently, XopL, a T3E from the pepper pathogen Xanthomonas 
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campestris pv. vesicatoria suppressing cell death and PTI, also was shown to have E3 ligase 
activity and to exhibit a novel architecture [24].  
 Another example is HopM1 produced by Pst DC3000 (HopM1DC3000), which mediates 
the proteasomal degradation of AtMIN7 (A. thaliana HopM1 Interactor 7), a guanine 
nucleotide exchange factor required for proper callose deposition, a PTI response [25].  At 
present it is not clear whether HopM1DC3000 is an E3 ligase itself or whether it recruits an 
unknown E3 ligase [25]. Furthermore, a T3E family of plant-type F-box proteins (named 
GALAs) is encoded in the genome of  Ralstonia solanacearum strains [26], whose members 
are thought to be part of SCF-type E3 ligases targeting as yet unknown host proteins for 
destruction [27, 28]. GALA7 is necessary for colonization of Medicago truncatula, and 
deletion of all seven GALA genes of R. solanacearum strain GMI1000 led to loss of 
pathogenicity on A. thaliana and reduced virulence on tomato [28]. In addition, F-box 
domain-containing proteins have been identified in Mesorhizobium loti, Xanthomonas 
campestris pv. vesicatoria, and P. syringae pv. phaseolicola. T3Es exhibiting E3 ligase 
activity have also been identified in bacteria pathogenic to animals [11], such as the NleG and 
NleL proteins from enterohaemorrhagic Escherichia coli [29, 30], the IpaH proteins of 
Shigella flexneri [31, 32], as well as SspH2 and SopA of Salmonella [33, 34]. Exploitation of 
the host proteasome for the enhancement of virulence may be quite widespread not only in 
pathogenic bacteria, but also in other pathogens such as the oomycete Phytophthora infestans 
which produces the RXLR motif-containing effector AVR3. AVR3 is translocated into the 
cytoplasm of host cells where it stabilizes the E3 ligase CMPG1, thereby suppressing 
CMPG1-dependent cell death triggered by pathogen recognition [35, 36 ]. 
 The examples briefly discussed above show that exploitation of the host proteasome 
function is employed by a wide variety of pathogens to enhance their virulence. In contrast, 
inhibition of the host proteasome has only recently been recognized as a virulence strategy of 
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certain pathogens. The rest of the review focuses on this recent development and covers 
important new research, extending a recent review with a similar topic [37]. 
 
Proteasome inhibition as a virulence strategy of plant pathogens 
A T3E with proteasome inhibiting activity 
An intriguing case of proteasome inhibition to enhance virulence has recently been reported 
by Üstün and colleagues [38], who identified the first T3E effector that suppresses 
proteasome activity.  The X. campestris T3E XopJ was shown to interact with the RPT6 
(regulatory particle ATPase 6) subunit of the 19S RP in yeast and in planta and to inhibit the 
proteasome. XopJ belongs to the YopJ T3E family of cysteine proteases/acyltransferases that 
is widely distributed in plant and animal pathogens as well as in plant symbionts and exhibits 
a characteristic catalytic triad [39]. Mutation of the catalytic triad as well as of the N-terminal 
myristoylation motif in XopJ abolished its proteasome-inhibiting ability, suggesting that 
enzymatic activity and membrane anchoring are required for proteasome inhibition. 
Comparisons of wild-type and mutant strains revealed that XopJ delayed host tissue 
degeneration and suppressed the accumulation of normal levels of SA and SA-dependent 
defense responses. It is presently not clear how this works mechanistically in view of the 
necessary localization of XopJ at the membrane. Future research will without doubt elucidate 
whether proteasome inhibition is the mode of action also of other members of the YopJ 
superfamily of T3Es. The study of Üstün and co-workers will likely also stimulate the search 
for T3E-type proteasome inhibitors outside the YopJ family of proteins in other pathogens. 
 
Syringolin A, a small-molecule proteasome inhibitor and virulence factor 
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Many potent small-molecule proteasome inhibitors belonging to different structural classes 
have been isolated from microbes and other organisms such as sponges and bryozoans (in 
which they probably are produced by symbiotic bacteria). While they draw intense attention 
as potential drug leads in the fight against certain cancer types [40], the function of these 
compounds for the biology of their producers remains in most cases completely unexplored. 
An exception is syringolin A (SylA), which is discussed below. 
 SylA was found to be secreted by strains of P. syringae pv. syringae (Pss). SylA is a 
tripeptide derivative consisting of an N-terminal valine and the two non-proteinogenic amino 
acids 3,4-dehydrolysine and 5-methyl-4-amino-2-hexenoic acid which form a twelve-
membered macrolactam ring. The N-terminal valine is joined head-to-head to another valine 
residue via an unusual ureido group (Figure 1). SylA is the major variant of a family of 
related compounds in which the valine residues can be substituted by isoleucine and/or the 
3,4-dehydrolysine may be replaced by lysine [37, 41-43]. SylA was shown to covalently 
attach to the catalytic N-terminal Thr residue of all catalytic subunits of the proteasome by a 
Michael-type 1,4-addition to the double bond at C4 in the 12-membered macrolactam ring, 
thereby irreversibly inhibiting catalytic activity [44]. Proteasome inhibition is probably 
specific because cysteine proteases and trypsin were not inhibited. Although all three catalytic 
activities of the proteasome are inhibited in vitro, the β5 subunit with its ChTL activity is 
most sensitive, while the β1 subunit conferring CL activity is least sensitive to inhibition by 
SylA [44]. Similar results were obtained in living plant cells by proteasome activity imaging 
and profiling experiments, in which SylA seemed to target preferentially proteasomes in the 
nucleus [45]. As recently elucidated in A. thaliana, SylA is efficiently taken up into plant cells 
by YELLOW STRIPE LIKE7 (YSL7) and YSL8 transporters [46], which belong to a plant-
specific oligopeptide transporter subfamily thought to be involved in transport and 
distribution of metal-nicotianamine complexes [47]. SylA is the founding member of a new 
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structural class of proteasome inhibitors dubbed syrbactins, which is characterized by the 12-
membered macrolactam ring and its functional α,β-unsaturated carbonyl group [48, 49]. 
 Spray-inoculation experiments with the SylA-producing wild-type strain Pss B728a 
and a SylA-negative mutant on their bean (Phaseolus vulgaris) host revealed the mutant to 
cause only about 30% of brown spot disease symptoms as compared to the wild type,  
identifying SylA as a virulence factor [44].  Further experiments revealed that SylA not only 
counteracted stomatal immunity (i.e. the pathogen-induced closure of the stomata, a PTI 
response dependent on the SA defense pathway and its key regulator NPR1[50-52]) in bean 
and Arabidopsis, but also inhibited other SA-dependent defense reactions such as PR gene 
induction [52]. Inhibition of the SA defense pathway by SylA is most likely due to inhibition 
of the proteasome-mediated turnover of the key regulator NPR1, which is necessary for its 
proper functioning as mentioned above. Furthermore, wound inoculation experiments with 
SylA-producing Pss strains on Nicotiana benthamiana recently revealed that SylA-mediated 
suppression of the SA defense pathway also helps the bacteria to escape local wound sites and 
to colonize adjacent regions along the vascular tissue because acquired resistance was 
impaired [53]. 
 
Occurrence of SylA synthetase genes in P. syringae strains 
The SylA synthetase, a  modular mixed non-ribosomal peptide synthetase/polyketide synthase 
(NRPS/PKS; see Box 1) is encoded by a gene cluster containing the five genes sylA, sylB, 
sylC, sylD, and sylE, the last three forming an operon [54, 55] (Figure 2A). Sequence and 
architecture of these genes implied a SylA biosynthesis model also experimentally supported 
in most of its aspects [54-58] (Figure 2B). Importantly, the structure of SylA with its 12-
membered macrolactam ring containing the functional α,β-unsaturated carbonyl group is 
reflected in the unique architecture of the sylD gene. This allows the identification in genome 
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data bases of homologous genes likely encoding structurally similar proteasome inhibitors in 
other taxa.  
 A recent genomics analysis of 19 diverse strains belonging to the P. syringae species 
complex revealed complete syl gene clusters with very high sequence conservation at 
conserved positions in the genomes of five of six strains belonging to group (subclade) 2, but 
not in strains belonging to groups 1 and 3, suggesting that SylA biosynthesis may be restricted 
to group 2 strains (Figure 3) [59]. Interestingly, group 2 strains seem to encode fewer T3Es (9 
to 16) than strains of the other groups. The comparatively low numbers of T3Es encoded in 
the analyzed group 2 strains, which correlates with the presence genes for the biosynthesis of 
the phytotoxins syringopeptin and syringomycin as well as of syringolin, suggests a virulence 
strategy distinct from the one of group 1 (which encompasses Pst DC3000) and group 3 
strains [59]. 
 
Conflicting action of virulence factors? 
Concomitant production of proteasome inhibitors with virulence factors requiring the host 
proteasome for their activity seems contradictory. In X. campestris pv. vesicatoria, the T3Es 
XopJ (proteasome inhibitor) and XopL (an E3 ligase) represent such a pair. The seeming 
conflict might be mitigated by spacial and/or temporal separation of production or activities 
[38]. In P. syringae, SylA production would seem to counteract host proteasome-requiring 
T3Es like HopAB2 and HopM1 or other virulence factors such as the JA- mimicking small 
molecule coronatine (COR). To our knowledge, COR synthetase genes or COR biosynthesis 
so far have not been found in strains carrying SylA synthetase genes [59, 60]. A homolog of 
HopAB2 (HopAB1, alias AvrPtoBB728a) occurs in the SylA-producing strain Pss B728a, 
which, however, has recently been shown to be defect in its E3 ligase activity [61]. In the case 
of HopM1, a variant of which occurs in Pss B728a as well as in most P. syringae strains, it is 
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also not clear whether it has a proteasome-dependent function related to the one of 
HopM1DC3000. HopM1 variants are phylogenetically and functionally diverse as evidenced by 
the fact that a variant from P. syringae pv. morspunorum did not complement a hopM1DC3000 
deletion mutant [59]. As mentioned above, if the potential to produce conflicting virulence 
factors does occur in the same strain, conflict might be resolved by differential regulation of 
biosynthesis during host colonization. 
 
Syrbactins in animal pathogens 
The determination of SylA’s structure revealed its similarity to the glidobactins (similar to 
cepafungins), a family of agents from soil bacteria with anti-tumor and antifungal activity 
isolated more than twenty years ago [62, 63]. Like SylA, glidobactin A (GlbA) contains a 12-
membered macrolactam ring with its characteristic α,β-unsaturated carbonyl group (Figure 1). 
GlbA was shown to inhibit the ChTL and TL activities of the eukaryotic proteasome by the 
same mechanism as SylA, whereas the CL activity was not inhibited at all [44]. The GlbA 
synthetase gene cluster (glbA-glbH) was cloned from the soil bacterium K481-B101, which 
belongs to the Burkholderiales [64]. Sequence and architecture of glbC and glbF, which, like 
their homologs sylD and sylC in Pss, encode a mixed NRPS/PKS synthetase, allowed to 
postulate a GlbA biosynthesis model which is analogous to the one for SylA and is 
experimentally supported.  [64, 65] (Figure 4). 
 Whereas disrupted nonfunctional glb-like gene clusters are present in strains of 
Burkholderia mallei (causing glanders in donkeys and horses), apparently intact glb-like gene 
clusters were found in the genome sequences of the human pathogens Burkholderia  
pseudomallei (the causing agent of melioidosis, β-proteobacteria), Burkholderia oklahomensis 
(β-proteobacteria), and Photorhabdus asymbiotica (γ-proteobacteria), In addition, an intact 
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glb-like gene cluster is also present in the insect pathogen and nematode symbiont 
Photorhabdus luminescens. This suggests that these pathogens have the potential to 
synthesize syrbactins (Figure 5) [64]. Indeed, transfer of the glb-like gene cluster of Ph. 
luminescens ssp. laumondii TT01 into Pseudomonas  putida resulted in GlbA production in 
the latter species [66]. Furthermore, GlbA as well as a variant named cepafungin I, the 
strongest proteasome inhibitor known to date, were isolated from Ph. luminescens cultures 
[67]. Similarly, GlbA and derivatives named luminmycins have been isolated from Ph. 
asymbiotica cultures and from crickets after infection with the pathogen [68]. Thus, these 
pathogens indeed produce syrbactin-type proteasome inhibitors, although future research must 
elucidate whether and how they are involved in virulence. 
Evolution of syrbactins 
Syrbactin synthetase-encoding genes so far have been found in a small but diverse group of 
plant and animal pathogens, suggesting that they were acquired by horizontal gene transfer. 
Comparison of sequence and architecture of the genes encoding the NRPS/PKS synthetase 
modules within syl and glb gene clusters reveals that the location of the starter module genes 
sylC and glbF is not conserved (Figure 2 and 3). In addition, and in contrast to sylD, whose 
closest homologs found in genome databases are the glbC-like genes, the closest homologs of 
the sylC gene are not the glbF-like genes. This suggests that sylD and glbC are descendants of 
a common ancestral gene, whereas sylC and glbF were independently recruited into the SylA 
and GlbA-like synthetase gene clusters, respectively. The starter modules not only activate 
different amino acids, but also catalyze the addition of tails with chemically different 
characters [56, 65]: in the case of SylA it is an ureido-valine, leading to a hydrophilic 
compound, whereas in GlbA it is a fatty acid, rendering the compound much more 
hydrophobic (Figure 1). This difference determines whether and how syrbactins are taken up 
into cells. GlbA has antifungal activity [62] and evidently must be taken up by fungal cells 
12 
 
such as yeast, whereas yeast is completely insensitive to SylA [46]. However, yeast can be 
rendered sensitive towards SylA by expression of the A. thaliana YLS7 and YSL8 plant-
specific transporters [46]. Thus the different tails may be viewed as adaptations to kingdom-
specific import mechanisms. 
 
Concluding remarks 
Whereas an increasing number of T3Es in both plant and animal pathogens have been found 
to require the host UPS for their mode of action, proteasome inhibition as a (potential) 
virulence strategy has only recently become apparent in a small but interesting group of plant 
and animal pathogens. This group will without doubt grow in the future, but it remains to be 
seen how prevalent proteasome inhibition as a virulence strategy of pathogens is. In view of 
the involvement of the UPS in regulatory pathways controlling almost all aspects of plant life, 
proteasome inhibition appears, due to the expected pleiotropic consequences, rather like a 
drastic sledgehammer method to suppress plant immunity.This contrasts with the often 
exquisitely precise interference with specific host defense signal transduction components that 
characterizes the action of many T3Es. However, this view may be exaggerated. Tight 
regulation of inhibitor production [55], the inhibitor-triggered de novo synthesis of 
proteasomes as suggested by transcriptome analyses [69], as well as spacial restriction of the 
inhibitor to the neighborhood of infection sites due to cellular uptake and proteasome binding  
may render proteasome inhibition much less pleiotropic than suggested by the known 
involvement of the UPS in a plethora of cellular processes. This is evidenced by the fact that 
SylA is not a deadly toxin that kills cells, but helps biotrophic bacteria to suppress the SA-
dependent defense pathway and to spread from wound infection sites [52, 53]. Further 
research will be required to determine the contribution of syrbactins and other proteasome 
inhibitors to the virulence of pathogens. 
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Figure legends 
Figure 1. Structure of syringolin A and glidobactin A. The α,β-unsaturated carbonyl group 
reacting with the N-terminal Thr of the catalytic proteasome subunits is given in red. As 
revealed by crystallography of the inhibitor bound to the yeast 20S CP, the double bond is 
opened and the C4 atom becomes linked to the oxygen in the side chain of the N-terminal Thr 
of the catalytic proteasome subunits, thus forming a stable ether linkage. The dipeptide bond 
given in green stabilizes the inhibitor upon proteasome binding, whereas the parts in blue 
determine active site specificity. The aliphatic tail of GlbA is shown in yellow. Adapted by 
permission from Macmillan Publishers Ltd: Nature [44], copyright 2008. 
 
Figure 2. SylA biosynthesis. (A) Gene cluster encoding the SylA synthetase of Pss strains. 
The sylA gene encodes a LuxR-type transcriptional activator regulating transcription of the 
sylB gene and the sylCDE operon [55], whereas the sylE gene encodes an exporter belonging 
to the major facilitator superfamily. The sylC and sylD genes encode the NRPS and PKS 
modules, which, together with the sylB gene product, compose the SylA synthetase. (B) SylA 
biosynthesis model. The SylA synthetase contains three NRPS modules with condensation 
(C), adenylation (A), and thiolation (T) domains and a type 1 PKS module with ketosynthase 
(KS), acyl-transferase (AT), dehydratase (DH), ketoreductase (KR), thiolation (T), and 
thioesterase (TE) domains. The SylC NRPS starter module activates valine (Val) and N-
acylates it with a second valine, thus forming an ureido linkage by incorporation of 
bicarbonate/CO2 [56, 57]. The first NRPS module of SylD is thought to activate lysine (Lys), 
which is desaturated to 3,4-dehydrolysine by the sylB gene product [43]. The second SylD 
NRPS module is thought to activate valine, which, after condensation/decarboxylation to a 
malonate residue activated by the type I PKS module of SylD, results in a β-keto-thioester 
whose β-keto group is twofold reduced by the KR and DH domains, thus resulting in the 5-
22 
 
methyl-4-amino-2-hexenoic acid (MAH) moiety. Finally, lactam bond formation between the 
terminal carboxyl group and the ε-amino group of the 3,4-dehydrolysine moiety catalyzed by 
the TE domain of the PKS module leads to cyclization and release of the final product [58]. 
Genes, domains/proteins and the molecular entities they act upon are given in the same color 
shades. Adapted with permission from [54]. 
 
Figure 3. Bayesian phylogenetic tree of 19 P. syringae strains. Colored bars on the left 
indicate phylogenetic groups as originally defined in [70]. Strains labeled in blue contain 
complete syl gene clusters. Pathovar of strain designations (if not given in the text): Pgy, 
glycinea; Pph, phaseolicola; Pmo, mori; Pae, aesculi; Pta, tabaci; Pla, lachrymans; Cit, 
unknown; Pac, aceris; Ppi, pisi; Ptt, aptata; Pja, japonica; Por, oryzae; Pma maculicola; Pan, 
actinidiae; Pmp morsprunorum. Figure adapted from [59] with permission. 
 
Figure 4. GlbA biosynthesis. (A) The glbA synthetase gene cluster. The glbC, glbD, and glbF 
genes are shown in the same colors as their syl homologs in Figure 2. The glbA gene encodes 
a LysR-type transcriptional regulator [64], whereas glbE encodes an MbtH-like chaperone 
[65]. The function of the glbB, glbG, and glbH genes is currently unknown. (B) GlbA 
biosynthesis model. The GlbF NRPS starter module activates threonine (Thr) and N-acylates 
it with a coenzyme A-activated fatty acid [65]. The first NRPS module of GlbC is thought to 
activate lysine (Lys), which is oxidized to 4-hydroxylysine by an as yet unknown enzyme. 
The second NRPS module is thought to activate alanine (Ala), which, after 
condensation/decarboxylation to a malonate residue activated by the type I PKS module of 
GlbC, results in a diketide that is twofold reduced by the KR and DH domains, thus resulting 
in the 4-amino-2-pentenoic acid (APA) moiety. Macrolactam ring formation and release is 
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catalyzed by the TE domain. Genes, domains/proteins and the molecular entities they act upon 
are given in identical color shades. Adapted with permission from [64]. 
 
Figure 5. GlbA-like synthetase gene clusters in animal pathogens. Homolgous genes are 
shown in identical colors. Hatched B. mallei genes indicate non-functionality due to 
transposon (Tn) insertions and additional strain-specific mutations and rearrangements. 
Accession numbers of proteins encoded by functional gene clusters are as follows: K481-
B101: CAL80819-CAL80826; B. pseudomallei K96243: YP_111277-YP_111273; B. 
oklahomensis C6786: WP_010109152-WP_010109148; Ph. luminescens ssp. luminescens 
TT01: NP_929149-NP_929145; Ph. asymbiotica ssp. asymbiotica (ATCC 43949): 
CAR67624-CAR67620. Adapted with permission from [64]. 
 
Box 1. Non-ribosomal peptide and polyketide synthesis by the thiotemplate mechanism 
NRPS are large modular enzymes which synthesize peptides without the involvement of 
ribosomes and mRNA templates [71-73]. Each module typically contains condensation (C), 
adenylation (A), thiolation (T), and optional tailoring domains. Exceptions are starter 
modules, which normally do not contain a C domain. The A domain catalyzes the adenylation 
of a cognate amino acid, which becomes attached via a thioester linkage to the 
phosphopantethein prosthetic group of the T domain. Peptide bond formation between amino 
acids bound to two adjacent modules as well as release of the upstream amino acid from its T 
domain is catalyzed by the C domain of the downstream module. Release of the assembled 
product, which is often cyclized, is catalyzed by the thioeserase (TE) domain in the last 
module. In linear NRPS, this so-called thiotemplate mechanism leads to an assembly line in 
which the sequence of the modules as encoded in the genome determines the amino acid 
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sequence of the peptide product (e.g. as in the SylA synthetase). In non-linear NRPS, modules 
may act in a sequence different from the one in which they are encoded on the chromosome 
(e.g. as in the GlbA synthetase).  
 Modules of type I (modular) PKS  usually contain acyltransferase (AT), ketosynthase 
(KS), and T domains as well as optional ketoreductase (KR), dehydratase (DH), and 
enoylreductase (ER) domains. Attachment of coenzyme A-activated malonyl (sometimes 
methylmalonyl, or, in starter modules, acetyl) moieties to the T domain via a thioester bond is 
catalyzed by the AT domain. Condensation/decarboxylation of adjacent malonyl residues by 
the KS domain (which is absent in starter modules) results in a polyketide [71, 74]. β-keto 
groups can be reduced by the consecutive action of optional KR, DH, and ER domains, 
resulting in β-hydroxyl groups, α,β-unsaturated double bonds (as in SylA and GlbA), or α,β-
saturated bonds, respectively. As in NRPS, the final PKS product is released, often in a 
cyclized form, by the TE domain of the last module. Similar to the SylA and GlbA 
synthetases, NRPS and PKS modules often occur together and form mixed NRPS/PKS. 
 
Box2. Outstanding questions 
• How prevalent is proteasome inhibition as a virulence strategy in pathogens? 
• How widespread is the production of syrbactin-type proteasome inhibitors in plant and 
animal pathogens, and in microbes in general? 
• What is the function of syrbactin-type proteasome inhibitors in the animal/human 
pathogens? Do they also enhance virulence? Could they have a function in symbiosis 
(e.g. in Photorhabdus luminescens)? 
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• In addition to XopJ of X. campestris, are other type III effectors, both within and 
outside the YopJ family, interfering with proteasome function? 
 
